|
Market Closed -
TEL AVIV STOCK EXCHANGE
10:24:11 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 1,675.00 ILa | -0.83% |
|
+4.10% | +3.52% |
| 09-08 | InterCure Regains Nasdaq Compliance | MT |
| 08-24 | InterCure Ltd. announced that it has received ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors. | CI |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 402B | 0.44% | 3.59% | 11.37% | 3.38% | 3.16x | |
| 75.6B | 8.97% | 15.93% | - | 11.28% | 2.92x | |
| 2.31B | -9.03% | -13.44% | -14.32% | -10.26% | 3.74x | |
| 26.86B | 5.53% | 11.35% | 10.4% | 4.7% | 2.8x | |
| 11.04B | 8.99% | 15.94% | 16.03% | 6.91% | 2.41x | |
| 13.95B | 6.28% | 14.35% | 16.52% | 7.49% | 2.1x | |
| 3.65B | 17.52% | 19.11% | 29.94% | 10.97% | 2.13x | |
| 21.31B | 6.6% | 17.38% | 36.32% | 5.2% | 2.25x | |
| 6.34B | 8.16% | 14.4% | 6.02% | 3.18% | 2.48x | |
| 10.84B | 7.86% | 16.57% | 21.28% | 4.48% | 0.9x | |
| 12.91B | 1.48% | 3.52% | 10.82% | 3.09% | 4.17x | |
| 2.69B | 7.7% | 11.47% | 21.95% | 9.06% | 0.94x | |
| 5.94B | 9.54% | 15.84% | 25.14% | 8.31% | 1.88x | |
| 23.05B | 4.98% | 9.31% | 6.51% | 3.03% | 2.76x | |
| 13.64B | 5.47% | 15.35% | - | 4.3% | 3.44x | |
| 3.2B | 14.5% | 20.59% | 14.97% | 9.27% | -0.47x | |
| 17.36B | 8.57% | 11.48% | 21.36% | 9.93% | 1.78x | |
| 5.06B | 6.8% | 9.6% | 18.97% | - | 2.83x | |
| 893M | 17.23% | 21.45% | 14.33% | 8.89% | 0.98x | |
| Average | 34.67B | 7.24% | 12.3% | 15.74% | 5.73% | 2.28x | |
| Weighted average by Cap. | 106B | 4.81% | 9.18% | 11.75% | 4.72% | 2.69x |
- Stock Market
- Stocks
- INCR Stock
- Sector InterCure Ltd.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
